Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
235 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Closed (4)

Medical Condition

  • Show all (1755)
  • Addiction (19)
    • Alcohol (2)
    • (-) Cocaine (2)
    • Marijuana (2)
    • Nicotine (3)
    • Opioids (8)
  • Allergy, Asthma, & Immunology (13)
    • (-) Allergy (1)
    • Asthma (9)
  • All of Us Research Program - NIH (1)
  • Autoimmune Disorders (29)
  • Blood Disorders (33)
  • Bone & Muscle (10)
  • Cancer (564)
  • Child Development (4)
  • COVID-19 (Coronavirus) (36)
  • Critical Illness (1)
  • Diabetes (21)
  • Ear, Nose and Throat (12)
  • Endocrine & Metabolic Disease (12)
  • Eye (7)
  • Gastrointestinal and Digestive Diseases (26)
  • Hair and Skin Disorders (3)
  • Headaches (5)
  • Healthy Volunteers (187)
  • Heart Disease (130)
    • Arterial Disease (8)
    • Cardiomyopathy (6)
    • (-) Carotid Artery Stenosis (1)
    • Coronary Artery Disease (9)
    • Heart Failure (10)
    • High Blood Pressure (10)
    • Peripheral Arterial Disease (6)
    • Valve Disease (30)
  • Infectious Disease (49)
  • Insomnia (2)
  • Kidney Disease (12)
  • Liver Disease (53)
  • Lung Disease (31)
  • Meniere's Disease (1)
  • Neurological Disorders (165)
  • Nutrition (6)
  • Obesity (10)
  • Obstetrics & Gynecology (55)
  • Pain Management (1)
  • Pediatrics (103)
  • Psychiatric Disorders (69)
  • Rehabilitation (9)
  • Stroke (7)
  • Surgery (7)
  • Transplant (48)
  • Urology (4)
  • Vascular Conditions (10)
Displaying 1 - 4 of 4

Study of Remibrutinib (LOU064) in Patients with Peanut Allergy

Condition: Allergy, Asthma, & Immunology / Allergy
Investigator: Joyce Yu, MD
Status: Closed
The study population includes up to 110 adult male and female participants ages 18-55 years. Participants may have multiple food allergies but must be peanut allergic in order to be included. Safety assessments will include the following: physical examination, vital signs, laboratory evaluations, and ECG (electrocardiogram).
Read More

Behavioral therapy in combination with medication treatment (if needed) for cocaine dependence

Condition: Addiction / Cocaine
Investigator: Frances Levin, MD
Status: Closed
This study will test a computer-based behavioral intervention to decrease cocaine use. Those who fail to achieve cocaine abstinence after the first 4 weeks while receiving the behavioral treatment will continue the behavioral treatment and be randomly assigned to one of two groups (one group will receive Adderall-XR (MAS-ER) and the other group will receive…
Read More

Patients with cartoid artery stenosis using the Roadsaver and Nanoparasol Embolic Systems

Condition: Heart Disease / Carotid Artery Stenosis
Investigator: Anthony Pucillo, MD
Status: Closed
This clinical trial is for patients diagnosed with carotid artery stenosis that are at high risk of a stroke. Carotid artery stenosis develops as a result of plaque buildup in the carotid artery. Over time plaque buildup creates a narrowing of the carotid artery, restricting the flow of blood. Thus, increasing the risk of stroke. In this research study the…
Read More

A study of two medications together to treat cocaine dependence

Condition: Addiction / Cocaine
Investigator: Frances Levin, MD
Status: Closed
The study is a two group outpatient study, one group receiving medications (Adderall-XR and topiramate) and one group receiving a placebo (inactive sugar pill). The study is looking at the safety and effectiveness of Adderall-XR (MAS-ER) and topiramate in the treatment of cocaine dependence. It is a 14-week trial that requires patients to attend visits 3…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science